Stock futures opened lower Sunday evening, as mounting concerns that companies would see lasting damage in the aftermath of the coronavirus pandemic spooked market participants....
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]...
(Bloomberg) -- U.S. equity futures declined in early trading, indicating the risk-off move that’s hit markets at the start of this month may have further to run.S&P 500 futures opened about 1% lower after global stocks posted a more than 2% slide on Friday. The Australian dollar slipped along with the pound and euro, though moves for most major currency pairs were subdued. Trading volumes may be light due to holidays in China and Japan, and Treasuries won’t trade until the London open. Oil began the week on the back foot.The more than 10% rally in world shares in April is being tested as investors assess efforts from countries starting to ease lockdown restrictions against fears of a second wave of infections and a steady steam of bad economic data. Earnings roll on this week, with firms including Disney, BMW, and Air France-KLM.“While it is unlikely that we will retest the...
Longer-term investors are going to sit tight since they know that time is on their side. They can afford to wait until gold hits an attractive value area before they take another shot at the long side....
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]...
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the market and buy […]...
(Bloomberg) -- U.S. cases increased 2.3% in the past 24 hours, below the one-week daily average. Gilead Sciences Inc. plans to get its drug remdesivir to patients within days after getting U.S. backing for emergency use.New York added the fewest new deaths in more than a month as hospitalizations declined. Russia reported more than 10,000 new cases, the highest number of the outbreak.The daily toll fell in the U.K. and Italy as leaders navigate reopening business without sparking new infections. Spain recorded the fewest deaths in more than six weeks.Key DevelopmentsVirus Tracker: global cases near 3.5 million; deaths top 246,000The big get bigger in pandemic-rearranged economyAn uneven curve flattens, with Manhattan ahead of the BronxRoche antibody test gets FDA emergency-use approvalU.S. reignites debate over Wuhan lab as disease originJanuary? Autumn? Doctors debate arrival time for a vaccineSubscribe to a daily update on the virus from Bloomberg’s Prognosis team here. Click VRUS...
